USA – Mendel, a San Jose, CA-based provider of a clinical artificial intelligence and natural language processing platform, raised $40M in Series B funding.
The round was led by Oak HC/FT with participation from DCM.
The company intends to use the funds to expand its team of AI and engineering teams and scale the commercial organization and accelerate the release of its product, Resolve, which consolidates clinical information to create a coherent longitudinal view of the patient journey.
Led by CEO Karim Galil, Mendel is a machine that can read and understand medicine. It uses novel AI technology to absorb clinical data in medical literature as well as patient health records, to enable a wide range of Real World Data applications.
21/04/2022
